DVA - DaVita 2022 EPS guidance range includes consensus as quarterly net income falls 19%
- DaVita Healthcare Partners' ( NYSE: DVA ) 2022 EPS guidance of $7.50-$8.50 includes the analyst consensus of $7.84 as the kidney dialysis services provider beat on the bottom line .
- However, net income of ~$284.6M in the quarter was a ~19% decline from the year-ago period ($2.38 net income per share, basic vs. $2.76).
- Revenue of ~$2.9B was a slight 0.3% increase from Q2 2021 and in-line with expectations.
- Dialysis patient services of $2.8B was flat compared to the year-ago period.
- Overall operating expenses increased 3% to ~$2.5B. The largest increase was in patient care costs ~3% to $2B.
- Seeking Alpha contributor Karreta Advisors is bullish on DaVita ( DVA ) saying the shares look cheap now .
For further details see:
DaVita 2022 EPS guidance range includes consensus as quarterly net income falls 19%